Performance of patients with NASH on the CLDQ and SF-36 questionnaires
| Mean±SD | Comparison p | |
|---|---|---|
| CLDQ | ||
| AS | 5.5±1.7 | – |
| FA | 4.6±1.6 | – |
| SS | 5.7±1.2 | – |
| AC | 5.8±1.3 | – |
| EF | 5.7±1.0 | – |
| WO | 5.3±1.4 | – |
| Total | 5.4±1.2 | – |
| SF-36 | ||
| PF | 50.2±9.4 | 0.86 |
| RP | 45.1±13.5 | <0.01 |
| BP | 47.8±9.6 | 0.05 |
| GH | 39.7±12.2 | <0.01 |
| VT | 44.5±12.8 | <0.01 |
| SF | 48.7±11.3 | 0.33 |
| RE | 49.5±10.7 | 0.66 |
| MH | 49.3±9.6 | 0.39 |
| PCS | 44.2±11.8 | <0.01 |
| MCS | 49.3±9.6 | 0.54 |
AC, activity; AS, abdominal symptoms; BP, body pain; CLDQ, Chronic Liver Disease Questionnaire; EF, emotional function; FA, fatigue; GH, general health; NASH, non-alcoholic steatohepatitis; MH, mental health; PF, physical functioning; RE, role emotional; RP, role physical; SF, social function; SF-36, Short-Form 36; SS, systemic symptoms; VT, vitality; WO, worry.